Eternity Healthcare Inc. announced that they are in development of a noninvasive sugar monitoring device using saliva instead of blood. There are an estimated 28 million diabetics in the United States and this number is growing. The worldwide number of diabetics is estimated to be over 200 million.

Diabetic patients are divided into type 1 and type 2. Type 1 diabetics require painful finger pricking and insulin injections 3-5 times a day and about 50% of the type 2 diabetics also require painful finger pricking and insulin injections. Currently the diabetic patients require using blood drawn from fingertips for testing of the blood sugar level. A drop of blood from the fingertip is placed on a strip which is then inserted into a monitoring device, known as glucose monitor device.

Using electrochemical reaction, the device provides the sugar level on which the patients determine whether he requires an insulin injection or not and if so, what dosage. Over 10 million glucose monitor devices, and several hundred million test strips are sold annually. The Global Blood Glucose Monitoring Devices Market was valued at USD 8.9 billion in 2010.

The Worldwide Glucose monitoring devices market is expected to be more than USD 16 billion by 2014.